Clearly defining the cost structures so that Doctors, Insurance Companies, and patients feel empowered to use personalized medicine to their advantage is what today’s guest believes is one of the best next steps we can take in healthcare.
In this Part 1 of 2 interviews, we are joined by Dr. Carmen Alfonso, who is the Senior Medical Director of Blue Cross Blue Shield Advantage of Arizona and has incredible insights into genomic mapping and how genetic testing would ultimately serve patients long term.
Join us as we discuss:
—------------
Stay connected with our host, Perry Dimas, here on LinkedIn!
Clearly defining the cost structures so that Doctors, Insurance Companies, and patients feel empowered to use personalized medicine to their advantage is what today’s guest believes is one of the best next steps we can take in healthcare.
In this Part 1 of 2 interviews, we are joined by Dr. Carmen Alfonso, who is the Senior Medical Director of Blue Cross Blue Shield Advantage of Arizona and has incredible insights into genomic mapping and how genetic testing would ultimately serve patients long term.
Join us as we discuss:
—------------
Stay connected with our host, Perry Dimas, here on LinkedIn!